Grant: CIHR Fellowship
Direct Payment
$50,000.00
Role of phosphorylation in Neuroligin function and synapse maturation
EF 2008-09
Résumé
It is known that neurodevelopmental disorders have a strong genetic basis, yet the genes involved have not been clearly identified. Many of the genes associated with neurodevelopmental disorders, such as autism, code for proteins thought to be involved in synapse formation, fate and maintenance. In particular, mutations in multiple members of a family of synaptic proteins, called Neuroligins, have been detected in families with autism.
In association with this, several lines of evidence indicate that synaptic abnormalities may be the underlying neurological cause of neurodevelopmental disorders. Many neurodevelopmental disorders exhibit patterns indicative of abnormal or halted synaptic development and maturation. Thus, understanding the precise functional roles of the proteins implicated in both synapse maturation and function may promote understanding of the causes of neurodevelopmental disorders. This proposal aims to clarify the role of the role of the Neuroligin family of synaptic proteins in synapse fate, maintenance and function. Specifically, we will explore how modification of Neuroligins by addition of a phosphate group, in a process called phosphorylation, can modify their function at synapses. Phosphorylation is of particular interest since it has been shown to act as a dynamic "on-off switch" rapidly modifying the function of numerous proteins, including others known to be involved in synapse development and remodeling. Ultimately, further understanding of synaptic protein function may promote the development of therapeutic targets for reducing the severity, or preventing the onset of symptoms of neurodevelopmental disorders.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
174191
Name
Hines Rochelle M
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Role of phosphorylation in Neuroligin function and synapse maturation
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$50,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Adhesion Molecule; Autism; Excitation; Inhibition; Neurodevelopment; Neuroligin; Phosphorylation; Synapse
Abstract
It is known that neurodevelopmental disorders have a strong genetic basis, yet the genes involved have not been clearly identified. Many of the genes associated with neurodevelopmental disorders, such as autism, code for proteins thought to be involved in synapse formation, fate and maintenance. In particular, mutations in multiple members of a family of synaptic proteins, called Neuroligins, have been detected in families with autism.
In association with this, several lines of evidence indicate that synaptic abnormalities may be the underlying neurological cause of neurodevelopmental disorders. Many neurodevelopmental disorders exhibit patterns indicative of abnormal or halted synaptic development and maturation. Thus, understanding the precise functional roles of the proteins implicated in both synapse maturation and function may promote understanding of the causes of neurodevelopmental disorders. This proposal aims to clarify the role of the role of the Neuroligin family of synaptic proteins in synapse fate, maintenance and function. Specifically, we will explore how modification of Neuroligins by addition of a phosphate group, in a process called phosphorylation, can modify their function at synapses. Phosphorylation is of particular interest since it has been shown to act as a dynamic "on-off switch" rapidly modifying the function of numerous proteins, including others known to be involved in synapse development and remodeling. Ultimately, further understanding of synaptic protein function may promote the development of therapeutic targets for reducing the severity, or preventing the onset of symptoms of neurodevelopmental disorders.
Competitiondate
200810
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hines, Rochelle M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $50,000~ $0~